Dietary Cholesterol Activates Ral Pathway, Affecting LDLR Turnover

A study published online in Nature on June 24, 2026, details how chronic dietary cholesterol intake activates Ral GTPases, a critical step in regulating low-density lipoprotein receptor (LDLR) turnover. The research identifies RalBP1–REPS1 and Cathepsin A (CTSA) as key components in this pathway. These interactions lead to increased internalization and lysosomal degradation of LDLR, ultimately hindering the body's ability to clear cholesterol from the bloodstream.

The findings suggest that the activation of Ral GTPases by dietary cholesterol plays a significant role in reducing the efficiency of cholesterol clearance mechanisms. This process involves the recruitment of specific proteins that facilitate the removal of LDLR from the cell surface and its subsequent breakdown within lysosomes. The study establishes a direct link between sustained high cholesterol consumption and the impairment of this vital cellular process.

Furthermore, the research indicates that inhibiting CTSA can restore LDLR function. This discovery presents a potential therapeutic avenue for managing cardiovascular disease, which is often linked to high cholesterol levels. By targeting CTSA, it may be possible to counteract the negative effects of dietary cholesterol on LDLR turnover and improve cholesterol homeostasis. The study was published in the journal Nature with the DOI 10.1038/s41586-026-10697-z.